June 11, 2009 09:00 ET

SOHM India Expands Distribution Network for Generic Pharmaceuticals in Four Northern States in India

SOHM India Securing Market Share in India's $10 Billion Domestic Pharmaceutical Market With Annual Growth Rates Doubling From 7% to 14% Over the Past Couple Years

BUENA PARK, CA--(Marketwire - June 11, 2009) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that the Company has expanded its distribution network for generic pharmaceuticals in four Northern states of India. The domestic pharmaceutical market in India is significant at around $10 billion in annual sales. Annual growth rates have doubled for the domestic market from 7% to 14% over the past couple years. The Company expects pharmaceutical sales in India to be a significant contributor to revenue and earnings in 2009.

India's population is in excess of 1 billion, and its growing middle class has pushed growth in the generic pharmaceutical market for both life-saving and life-style drugs. India is one of the only emerging markets that has many of the leading pharmaceutical multinationals listed and publicly traded on domestic stock exchanges, including Pfizer, Novartis, and GlaxoSmithKline.

"By 2010, between $50 and $80 billion of brand-name drugs around the globe will no longer have patent protection," stated Vice President for Corporate Strategy at SOHM, Inc. "This is a huge advantage for Indian based generic pharmaceutical manufacturing companies like SOHM as we can immediately start producing and selling generic drugs at a significant discount while still maintaining significant profit margins. Our contract manufacturing in India also allows us to cost-effectively manufacture compounds in very small quantities and complete sales orders that large drug manufacturers cannot profitably complete. We have effectively positioned the Company in this niche allowing us to create revenue and earnings in a large and underserved area of the India pharmaceutical market."

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact